COVID-19 vaccines for children in LMICs: another equity issue

The Lancet
Aug 28, 2021 Volume 398 Number 10302 p725-816, e11
https://www.thelancet.com/journals/lancet/issue/current

 

Comment
COVID-19 vaccines for children in LMICs: another equity issue
Beate Kampmann, Uduak Okomo
During deliberations on the potential benefits of COVID-19 vaccines for CYP, it is important to recognise that this pandemic has already deprived more than 8 million children, primarily in LMICs, from life-saving, routine childhood vaccines.19 Immunisation services are preoccupied with the implementation of COVID-19 vaccine programmes for adults. At present, greater benefit for children’s health globally will be derived by delivering the health interventions we already know will save their lives, such as vaccines against measles and other vaccine-preventable diseases, than by focusing on delivering COVID-19 vaccines to part of a population that does not currently represent a strategic priority in the response to this pandemic. Although maybe not equitable, we believe this approach is more important for the health of CYP at this point in time.